Literature DB >> 26722417

Effect of apolipoprotein B mRNA-editing catalytic polypeptide-like protein-3G in cervical cancer.

Yanhua Xu1, Junhong Leng2, Fang Xue1, Ruiqian Dong3.   

Abstract

Cervical cancer is one of the most common gynecologic cancers. The role of apolipoprotein B mRNA-editing catalytic polypeptide-like protein-3G (APCBEC-3G) in cervical cancer has yet to be elucidated. This study intends to explore the effect of APCBEC-3G on cervical cancer cell proliferation and invasion. In vitro, the cervical cancer cell line Hela was transfected by APCBEC-3G plasmid. The mRNA and protein expression levels of APCBEC-3G were detected by Real-time PCR and Western blot, respectively. Cervical cancer cell proliferation was determined by MTT. Transwell assay was applied to measure the effect of APCBEC-3G on cell invasion. APCBEC-3G mRNA and protein increased significantly after transfection (P<0.05) and cervical cancer cell proliferation and invasive ability were decreased significantly (P<0.05). APOBEC-3G serves as a suppressor of cervical cancer cell proliferation and invasion. Our research provides theoretical basis for further investigation APOBEC-3G effect in cervical cancer occurrence and development.

Entities:  

Keywords:  APOBEC-3G; cervical cancer; invasion; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26722417      PMCID: PMC4680362     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  21 in total

Review 1.  APOBEC deaminases-mutases with defensive roles for immunity.

Authors:  Courtney Prochnow; Ronda Bransteitter; XiaoJiang S Chen
Journal:  Sci China C Life Sci       Date:  2009-11-13

Review 2.  AID and APOBEC deaminases: balancing DNA damage in epigenetics and immunity.

Authors:  Don-Marc Franchini; Svend K Petersen-Mahrt
Journal:  Epigenomics       Date:  2014       Impact factor: 4.778

3.  APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.

Authors:  David W Cescon; Benjamin Haibe-Kains; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

4.  Annual report on status of cancer in China, 2011.

Authors:  Wanqing Chen; Rongshou Zheng; Hongmei Zeng; Siwei Zhang; Jie He
Journal:  Chin J Cancer Res       Date:  2015-02       Impact factor: 5.087

5.  Knowledge of human papillomavirus vaccination and related factors among parents of young adolescents: a nationwide survey in China.

Authors:  Shao-Kai Zhang; Xiong-Fei Pan; Shao-Ming Wang; Chun-Xia Yang; Xiao-Hong Gao; Zeng-Zhen Wang; Man Li; Ze-Fang Ren; Quan-Qing Zheng; Wei Ma; Fang-Hui Zhao; You-Lin Qiao
Journal:  Ann Epidemiol       Date:  2015-01-07       Impact factor: 3.797

Review 6.  Novel factors interfering with human immunodeficiency virus-type 1 replication in vivo and in vitro.

Authors:  E Vicenzi; G Poli
Journal:  Tissue Antigens       Date:  2013-02

7.  APOBEC3B mutagenesis in cancer.

Authors:  Kawai J Kuong; Lawrence A Loeb
Journal:  Nat Genet       Date:  2013-09       Impact factor: 38.330

8.  APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.

Authors:  Stephen Henderson; Ankur Chakravarthy; Xiaoping Su; Chris Boshoff; Tim Robert Fenton
Journal:  Cell Rep       Date:  2014-06-05       Impact factor: 9.423

9.  FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.

Authors:  Catherine E Waters; Joshua C Saldivar; Zaynab A Amin; Morgan S Schrock; Kay Huebner
Journal:  Oncotarget       Date:  2015-02-20

10.  APOBEC3B gene overexpression in non-small-cell lung cancer.

Authors:  Hidefumi Sasaki; Ayumi Suzuki; Tsutomu Tatematsu; Masayuki Shitara; Yu Hikosaka; Katsuhiro Okuda; Satoru Moriyama; Motoki Yano; Yoshitaka Fujii
Journal:  Biomed Rep       Date:  2014-03-18
View more
  1 in total

1.  Correlation of APOBEC3G Polymorphism with Human Papillomavirus (HPV) Persistent Infection and Progression of Cervical Lesions.

Authors:  Shuang Sui; Hongxiang Chen; Lili Han; Lin Wang; Mayineur Niyazi; Kaichun Zhu
Journal:  Med Sci Monit       Date:  2019-09-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.